Skip to main content
Erschienen in: Current Reviews in Musculoskeletal Medicine 3/2018

03.07.2018 | Prosthetic Joint Infection (S Nodzo and N Frisch, section editors)

The Use of Antibiograms in Orthopedic Surgery

verfasst von: Scott R. Nodzo, Nicholas B. Frisch

Erschienen in: Current Reviews in Musculoskeletal Medicine | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Organism identification and antibiotic selection remain a critical component of periprosthetic joint infection (PJI) treatment. Prior to organism identification and/or the availability of antibiotic sensitivities, empiric antibiotics are routinely started. A basic understanding of a region or institutions antibiogram is paramount for selection of an empiric treatment regimen. Evolving antibiogram results and regional antibiotic resistance are important to follow as this may change antibiotic selection in some patient populations.

Recent Findings

The Clinical Laboratory and Standards Institute (CLSI) has created guidelines and standards for the creation and maintenance of antibiograms that should be followed by institutions. The infecting organism during PJI may be different in acute vs chronic infections and empiric therapy may change depending on the timing. Antibiotic prophylaxis for major procedures in certain patient populations should be critically evaluated based on regional and national antibiogram results.

Summary

The CLSI guides recommendations and antibiotic resistance testing techniques and should be consulted when creating an antibiogram. The local and regional antibiogram should be consulted prior to administration of empiric and prophylactic antibiotics.
Literatur
1.
Zurück zum Zitat Bozic KJ, Ong K, Lau E, Berry DJ, Vail TP, Kurtz SM, et al. Estimating risk in Medicare patients with THA: an electronic risk calculator for periprosthetic joint infection and mortality. Clin Orthop Relat Res. 2013;471(2):574–83.CrossRefPubMed Bozic KJ, Ong K, Lau E, Berry DJ, Vail TP, Kurtz SM, et al. Estimating risk in Medicare patients with THA: an electronic risk calculator for periprosthetic joint infection and mortality. Clin Orthop Relat Res. 2013;471(2):574–83.CrossRefPubMed
2.
Zurück zum Zitat Kamath AF, Ong KL, Lau E, Chan V, Vail TP, Rubash HE, et al. Quantifying the burden of revision Total joint arthroplasty for Periprosthetic infection. J Arthroplast. 2015;30(9):1492–7.CrossRef Kamath AF, Ong KL, Lau E, Chan V, Vail TP, Rubash HE, et al. Quantifying the burden of revision Total joint arthroplasty for Periprosthetic infection. J Arthroplast. 2015;30(9):1492–7.CrossRef
3.
Zurück zum Zitat •• Kapadia BH, Banerjee S, Cherian JJ, Bozic KJ, Mont MA. The economic impact of Periprosthetic infections after Total hip arthroplasty at a specialized tertiary-care center. J Arthroplast. 2016;31(7):1422–6. This study evaluated the econmic impact of total hip arthroplasty (THA) periprosthetic joint infection (PJI). They found patients treated for THA PJI cost three times more, had an increased length of stay, and increased hospital readmission compared to non-infected THA patients. CrossRef •• Kapadia BH, Banerjee S, Cherian JJ, Bozic KJ, Mont MA. The economic impact of Periprosthetic infections after Total hip arthroplasty at a specialized tertiary-care center. J Arthroplast. 2016;31(7):1422–6. This study evaluated the econmic impact of total hip arthroplasty (THA) periprosthetic joint infection (PJI). They found patients treated for THA PJI cost three times more, had an increased length of stay, and increased hospital readmission compared to non-infected THA patients. CrossRef
4.
Zurück zum Zitat Kapadia BH, McElroy MJ, Issa K, Johnson AJ, Bozic KJ, Mont MA. The economic impact of periprosthetic infections following total knee arthroplasty at a specialized tertiary-care center. J Arthroplast. 2014;29(5):929–32.CrossRef Kapadia BH, McElroy MJ, Issa K, Johnson AJ, Bozic KJ, Mont MA. The economic impact of periprosthetic infections following total knee arthroplasty at a specialized tertiary-care center. J Arthroplast. 2014;29(5):929–32.CrossRef
5.
Zurück zum Zitat Parvizi J, Pawasarat IM, Azzam KA, Joshi A, Hansen EN, Bozic KJ. Periprosthetic joint infection: the economic impact of methicillin-resistant infections. J Arthroplast. 2010;25(6 Suppl):103–7.CrossRef Parvizi J, Pawasarat IM, Azzam KA, Joshi A, Hansen EN, Bozic KJ. Periprosthetic joint infection: the economic impact of methicillin-resistant infections. J Arthroplast. 2010;25(6 Suppl):103–7.CrossRef
6.
Zurück zum Zitat Parvizi J, Erkocak OF, Della Valle CJ. Culture-negative periprosthetic joint infection. J Bone Joint Surg Am. 2014;96(5):430–6.CrossRefPubMed Parvizi J, Erkocak OF, Della Valle CJ. Culture-negative periprosthetic joint infection. J Bone Joint Surg Am. 2014;96(5):430–6.CrossRefPubMed
8.
Zurück zum Zitat Bax R, Bywater R, Cornaglia G, Goossens H, Hunter P, Isham V, et al. Surveillance of antimicrobial resistance--what, how and whither? Clin Microbiol Infect. 2001;7(6):316–25.CrossRefPubMed Bax R, Bywater R, Cornaglia G, Goossens H, Hunter P, Isham V, et al. Surveillance of antimicrobial resistance--what, how and whither? Clin Microbiol Infect. 2001;7(6):316–25.CrossRefPubMed
9.
Zurück zum Zitat Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 16th informational supplement 2007. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 16th informational supplement 2007.
10.
Zurück zum Zitat Clinical and Laboratory Standards Institute (CLSI). Analysis and presentation of cumulative antimicrobial susceptibility test data 2014. Clinical and Laboratory Standards Institute (CLSI). Analysis and presentation of cumulative antimicrobial susceptibility test data 2014.
11.
Zurück zum Zitat Hindler JF, Stelling J. Analysis and presentation of cumulative antibiograms: a new consensus guideline from the clinical and laboratory standards institute. Clin Infect Dis. 2007;44(6):867–73.CrossRefPubMed Hindler JF, Stelling J. Analysis and presentation of cumulative antibiograms: a new consensus guideline from the clinical and laboratory standards institute. Clin Infect Dis. 2007;44(6):867–73.CrossRefPubMed
12.
Zurück zum Zitat Ericsson HM, Sherris JC. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand B: Microbiol Immunol. 1971;217(Suppl 217):1–90. Ericsson HM, Sherris JC. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand B: Microbiol Immunol. 1971;217(Suppl 217):1–90.
13.
Zurück zum Zitat Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility testing for bacteria that grew aerobically. Approved Standard M7–A10. 2009. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility testing for bacteria that grew aerobically. Approved Standard M7–A10. 2009.
14.
Zurück zum Zitat Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clin Infect Dis. 2009;49(11):1749–55.CrossRefPubMed Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clin Infect Dis. 2009;49(11):1749–55.CrossRefPubMed
15.
Zurück zum Zitat Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45(4):493–6.CrossRefPubMed Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45(4):493–6.CrossRefPubMed
16.
Zurück zum Zitat Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2–A10. Clinical and Laboratory Standards Institute. 2009. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2–A10. Clinical and Laboratory Standards Institute. 2009.
17.
Zurück zum Zitat Citron DM, Ostovari MI, Karlsson A, Goldstein EJ. Evaluation of the E test for susceptibility testing of anaerobic bacteria. J Clin Microbiol. 1991;29(10):2197–203.PubMedPubMedCentral Citron DM, Ostovari MI, Karlsson A, Goldstein EJ. Evaluation of the E test for susceptibility testing of anaerobic bacteria. J Clin Microbiol. 1991;29(10):2197–203.PubMedPubMedCentral
18.
Zurück zum Zitat Baker CN, Stocker SA, Culver DH, Thornsberry C. Comparison of the E test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. J Clin Microbiol. 1991;29(3):533–8.PubMedPubMedCentral Baker CN, Stocker SA, Culver DH, Thornsberry C. Comparison of the E test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. J Clin Microbiol. 1991;29(3):533–8.PubMedPubMedCentral
19.
Zurück zum Zitat Barenfanger J, Drake C, Kacich G. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol. 1999;37(5):1415–8.PubMedPubMedCentral Barenfanger J, Drake C, Kacich G. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol. 1999;37(5):1415–8.PubMedPubMedCentral
20.
Zurück zum Zitat Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am. 2005;87(8):1746–51.PubMed Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am. 2005;87(8):1746–51.PubMed
21.
Zurück zum Zitat Fulkerson E, Valle CJ, Wise B, Walsh M, Preston C, Di Cesare PE. Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites. J Bone Joint Surg Am. 2006;88(6):1231–7.CrossRefPubMed Fulkerson E, Valle CJ, Wise B, Walsh M, Preston C, Di Cesare PE. Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites. J Bone Joint Surg Am. 2006;88(6):1231–7.CrossRefPubMed
22.
Zurück zum Zitat Aamot HV, Stavem K, Skramm I. No change in the distribution of types and antibiotic resistance in clinical Staphylococcus aureus isolates from orthopaedic patients during a period of 12 years. Eur J Clin Microbiol Infect Dis. 2015;34(9):1833–7.CrossRefPubMed Aamot HV, Stavem K, Skramm I. No change in the distribution of types and antibiotic resistance in clinical Staphylococcus aureus isolates from orthopaedic patients during a period of 12 years. Eur J Clin Microbiol Infect Dis. 2015;34(9):1833–7.CrossRefPubMed
23.
Zurück zum Zitat Oppegaard O, Mylvaganam H, Kittang BR. Beta-haemolytic group a, C and G streptococcal infections in western Norway: a 15-year retrospective survey. Clin Microbiol Infect. 2015;21(2):171–8.CrossRefPubMed Oppegaard O, Mylvaganam H, Kittang BR. Beta-haemolytic group a, C and G streptococcal infections in western Norway: a 15-year retrospective survey. Clin Microbiol Infect. 2015;21(2):171–8.CrossRefPubMed
24.
Zurück zum Zitat Ip D, Yam SK, Chen CK. Implications of the changing pattern of bacterial infections following total joint replacements. J Orthop Surg (Hong Kong). 2005;13(2):125–30.CrossRef Ip D, Yam SK, Chen CK. Implications of the changing pattern of bacterial infections following total joint replacements. J Orthop Surg (Hong Kong). 2005;13(2):125–30.CrossRef
25.
Zurück zum Zitat Bosco J, Bookman J, Slover J, Edusei E, Levine B. Principles of antibiotic prophylaxis in Total joint arthroplasty: current concepts. Instr Course Lect. 2016;65:467–75.PubMed Bosco J, Bookman J, Slover J, Edusei E, Levine B. Principles of antibiotic prophylaxis in Total joint arthroplasty: current concepts. Instr Course Lect. 2016;65:467–75.PubMed
26.
Zurück zum Zitat Tan TL, Springer BD, Ruder JA, Ruffolo MR, Chen AF. Is vancomycin-only prophylaxis for patients with penicillin allergy associated with increased risk of infection after arthroplasty? Clin Orthop Relat Res. 2016;474(7):1601–6.CrossRefPubMed Tan TL, Springer BD, Ruder JA, Ruffolo MR, Chen AF. Is vancomycin-only prophylaxis for patients with penicillin allergy associated with increased risk of infection after arthroplasty? Clin Orthop Relat Res. 2016;474(7):1601–6.CrossRefPubMed
27.
Zurück zum Zitat Crane JK, Hohman DW, Nodzo SR, Duquin TR. Antimicrobial susceptibility of Propionibacterium acnes isolates from shoulder surgery. Antimicrob Agents Chemother. 2013;57(7):3424–6.CrossRefPubMedPubMedCentral Crane JK, Hohman DW, Nodzo SR, Duquin TR. Antimicrobial susceptibility of Propionibacterium acnes isolates from shoulder surgery. Antimicrob Agents Chemother. 2013;57(7):3424–6.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat • Wright TE, Boyle KK, Duquin TR, Crane JK. Propionibacterium acnes susceptibility and correlation with hemolytic phenotype. Infect Dis (Auckl). 2016;9:39–44. This basic science study evaluted the antibiotic susceptibilites of clinical strains of Propionibacterium acnes ( P. acnes ). They found P. acnes with a hemolytic phenotype had significantly increased resistance to clindamycin as compared to non-hemolytic strains. CrossRef • Wright TE, Boyle KK, Duquin TR, Crane JK. Propionibacterium acnes susceptibility and correlation with hemolytic phenotype. Infect Dis (Auckl). 2016;9:39–44. This basic science study evaluted the antibiotic susceptibilites of clinical strains of Propionibacterium acnes ( P. acnes ). They found P. acnes with a hemolytic phenotype had significantly increased resistance to clindamycin as compared to non-hemolytic strains. CrossRef
29.
Zurück zum Zitat • Tan TL, Gomez MM, Kheir MM, Maltenfort MG, Chen AF. Should preoperative antibiotics be tailored according to Patient's comorbidities and susceptibility to organisms? J Arthroplast. 2017;32(4):1089–94.e3. This study supports the use of standard orthopedic antibiotic prophylaxis rather than indivudilized antibioitc therapy in high risk patients. In this retrospectice study they found no increase risk of infection when cefazolin or vancomycin monotherapy was used as thet preoperative antibioitc in high risk patients. CrossRef • Tan TL, Gomez MM, Kheir MM, Maltenfort MG, Chen AF. Should preoperative antibiotics be tailored according to Patient's comorbidities and susceptibility to organisms? J Arthroplast. 2017;32(4):1089–94.e3. This study supports the use of standard orthopedic antibiotic prophylaxis rather than indivudilized antibioitc therapy in high risk patients. In this retrospectice study they found no increase risk of infection when cefazolin or vancomycin monotherapy was used as thet preoperative antibioitc in high risk patients. CrossRef
30.
Zurück zum Zitat Courtney PM, Melnic CM, Zimmer Z, Anari J, Lee GC. Addition of vancomycin to cefazolin prophylaxis is associated with acute kidney injury after primary joint arthroplasty. Clin Orthop Relat Res. 2015;473(7):2197–203.CrossRefPubMed Courtney PM, Melnic CM, Zimmer Z, Anari J, Lee GC. Addition of vancomycin to cefazolin prophylaxis is associated with acute kidney injury after primary joint arthroplasty. Clin Orthop Relat Res. 2015;473(7):2197–203.CrossRefPubMed
31.
Zurück zum Zitat •• Bosco JA, Prince Rainier RT, Catanzano AJ, Stachel AG, Phillips MS. Expanded gram-negative antimicrobial prophylaxis reduces surgical site infections in hip arthroplasty. J Arthroplast. 2016;31(3):616–21. This retrospective study showed that by adding gram negative coverage to their preoperative antibioticy prophylaxis they were able to significantly reduce their periprosthetic joint infection rate. They decreased their infection rate from from 1.19% to 0.55% with the addtion of gram negative coverage. CrossRef •• Bosco JA, Prince Rainier RT, Catanzano AJ, Stachel AG, Phillips MS. Expanded gram-negative antimicrobial prophylaxis reduces surgical site infections in hip arthroplasty. J Arthroplast. 2016;31(3):616–21. This retrospective study showed that by adding gram negative coverage to their preoperative antibioticy prophylaxis they were able to significantly reduce their periprosthetic joint infection rate. They decreased their infection rate from from 1.19% to 0.55% with the addtion of gram negative coverage. CrossRef
32.
Zurück zum Zitat Pakyz AL. The utility of hospital antibiograms as tools for guiding empiric therapy and tracking resistance. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2007;27(9):1306–12.CrossRefPubMed Pakyz AL. The utility of hospital antibiograms as tools for guiding empiric therapy and tracking resistance. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2007;27(9):1306–12.CrossRefPubMed
33.
Zurück zum Zitat Zapantis A, Lacy MK, Horvat RT, Grauer D, Barnes BJ, O'Neal B, et al. Nationwide antibiogram analysis using NCCLS M39-a guidelines. J Clin Microbiol. 2005;43(6):2629–34.CrossRefPubMedPubMedCentral Zapantis A, Lacy MK, Horvat RT, Grauer D, Barnes BJ, O'Neal B, et al. Nationwide antibiogram analysis using NCCLS M39-a guidelines. J Clin Microbiol. 2005;43(6):2629–34.CrossRefPubMedPubMedCentral
Metadaten
Titel
The Use of Antibiograms in Orthopedic Surgery
verfasst von
Scott R. Nodzo
Nicholas B. Frisch
Publikationsdatum
03.07.2018
Verlag
Springer US
Erschienen in
Current Reviews in Musculoskeletal Medicine / Ausgabe 3/2018
Elektronische ISSN: 1935-9748
DOI
https://doi.org/10.1007/s12178-018-9496-x

Weitere Artikel der Ausgabe 3/2018

Current Reviews in Musculoskeletal Medicine 3/2018 Zur Ausgabe

Prosthetic Joint Infection (S Nodzo and N Frisch, section editors)

Intraoperative Considerations for Treatment/Prevention of Prosthetic Joint Infection

Prosthetic Joint Infection (S Nodzo and N Frisch, section editors)

Two-Stage Revision Arthroplasty for the Treatment of Prosthetic Joint Infection

Prosthetic Joint Infection (S Nodzo and N Frisch, section editors)

Risk Factors and Treatment Options for Failure of a Two-Stage Exchange

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.